Evidence map›Paper›PMID 37973811›Full record

ArticleScientific reports2023

Author Correction: JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders.

Geza Ambrus-Aikelin, Katsuyuki Takeda, Anthony Joetham, Milos Lazic, Davide Povero, Angelina M Santini, Rama Pranadinata, Casey D Johnson, Matthew D McGeough, Federico C Beasley and 9 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Geza Ambrus-AikelinJecure Therapeutics, San Diego, CA, USA.
Katsuyuki TakedaDepartment of Pediatrics, National Jewish Health, Denver, CO, USA.
Anthony JoethamDepartment of Pediatrics, National Jewish Health, Denver, CO, USA.
Milos LazicJecure Therapeutics, San Diego, CA, USA.
Davide PoveroJecure Therapeutics, San Diego, CA, USA. povero.davide@mayo.edu.
Angelina M SantiniJecure Therapeutics, San Diego, CA, USA.
Rama PranadinataJecure Therapeutics, San Diego, CA, USA.
Casey D JohnsonDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Matthew D McGeoughDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Federico C BeasleyJecure Therapeutics, San Diego, CA, USA.
Ryan StansfieldJecure Therapeutics, San Diego, CA, USA.
Christopher McBrideJecure Therapeutics, San Diego, CA, USA.
Lynnie TrzossJecure Therapeutics, San Diego, CA, USA.
Hal M HoffmanDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Ariel E FeldsteinDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Jeffrey A StaffordJecure Therapeutics, San Diego, CA, USA.
James M VealJecure Therapeutics, San Diego, CA, USA.
Gretchen BainJecure Therapeutics, San Diego, CA, USA.
Erwin W GelfandDepartment of Pediatrics, National Jewish Health, Denver, CO, USA.
University of California San Diego · USNational Jewish Health · USMayo Clinic in Florida · USUniversity of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37973811
PMCPMC10654444
OpenAlexW4388723808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.